Japanese Yen and Swiss Franc Gain as DeepSeek AI Model Sparks SafeHaven Rush EV Owners Face Controversial Tax Proposal Market Implications Analyzed Brookings Hutchins Center Fiscal Impact Measure Gauging Fiscal Policys Economic Influence Hunter Biden Suggests Fathers Withdrawal From 2024 Race Linked to Epstein Class Allegations Morgan Stanley Lowers Edison International Price Target Amid Utility Sector Review Trainline Raises Fiscal Year Guidance for Second Time Amid Strong Travel Demand UG Q2 2025 Earnings Profitability Maintained Amid Modest Stock Reaction RNGR Q1 2026 Earnings EPS Misses Estimates by Nearly 39 Amid Operational Headwinds UAVS Q3 2023 Earnings Narrowing Losses and Market Optimism Amid Strategic Pivot FVCBankcorp Inc Q1 2026 Earnings EPS Beats Estimates by 4 Amid Challenging Banking Landscape ResMed Q1 2026 Earnings EPS Beats Estimates but Stock Slips VIR Q1 2026 Earnings Significant EPS Miss Despite Minimal Revenue Westwater Resources WWR Holds Steady Near 056 Key Levels Remain in Focus Merchants Bancorp MBIN Holds Steady Near 4678 as Key Levels Define Trading Range Gloo Holdings Inc GLOO Slips 125 as Stock Tests Key Support Zone Precision BioSciences DTIL Jumps 484 as Biotech Sentiment Improves Linkhome Holdings Inc LHAI Holds Steady at 090 as Key Levels Define Trading Range US CPI Report for April 2026 Released TD Economics Provides Analysis RB Global Inc RBA Q1 2026 Earnings EPS Slightly Beats Estimates Stock Rises on Positive Momentum Socket Mobile Inc SCKT Rallies 24 as Momentum Builds at 085 Recursion Pharmaceuticals RXRX Slips 13 as Biotech Stock Tests Key Support Near 282 AleAnna Inc ANNA Surges 6 as Momentum Builds Above Key Support Corporacion America Airports CAAP Gains 236 Support and Resistance Levels in Focus Pantages Capital Acquisition Corporation Right PGACR Holds Steady at 021 Key Levels in Focus Insight Digital Partners II DYOR Edges Higher Near Resistance on Minimal Price Action HCM III Acquisition Corp HCMA Holds Near Support Amid Low Volatility Arcus Biosciences RCUS Gains 225 as Biotech Momentum Builds